JP2015129652A5 - - Google Patents

Download PDF

Info

Publication number
JP2015129652A5
JP2015129652A5 JP2014000417A JP2014000417A JP2015129652A5 JP 2015129652 A5 JP2015129652 A5 JP 2015129652A5 JP 2014000417 A JP2014000417 A JP 2014000417A JP 2014000417 A JP2014000417 A JP 2014000417A JP 2015129652 A5 JP2015129652 A5 JP 2015129652A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence shown
peptide consisting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014000417A
Other languages
English (en)
Japanese (ja)
Other versions
JP6312302B2 (ja
JP2015129652A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014000417A priority Critical patent/JP6312302B2/ja
Priority claimed from JP2014000417A external-priority patent/JP6312302B2/ja
Publication of JP2015129652A publication Critical patent/JP2015129652A/ja
Publication of JP2015129652A5 publication Critical patent/JP2015129652A5/ja
Application granted granted Critical
Publication of JP6312302B2 publication Critical patent/JP6312302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014000417A 2014-01-06 2014-01-06 脳梗塞の診断マーカー Active JP6312302B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014000417A JP6312302B2 (ja) 2014-01-06 2014-01-06 脳梗塞の診断マーカー

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014000417A JP6312302B2 (ja) 2014-01-06 2014-01-06 脳梗塞の診断マーカー

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018050502A Division JP6499342B2 (ja) 2018-03-19 2018-03-19 脳梗塞の診断マーカー

Publications (3)

Publication Number Publication Date
JP2015129652A JP2015129652A (ja) 2015-07-16
JP2015129652A5 true JP2015129652A5 (enExample) 2017-06-22
JP6312302B2 JP6312302B2 (ja) 2018-04-18

Family

ID=53760486

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014000417A Active JP6312302B2 (ja) 2014-01-06 2014-01-06 脳梗塞の診断マーカー

Country Status (1)

Country Link
JP (1) JP6312302B2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6942036B2 (ja) * 2017-11-30 2021-09-29 藤倉化成株式会社 脳梗塞の発症リスクを高感度に検出する体液抗体バイオマーカー
CN114594273B (zh) * 2022-05-09 2024-02-27 上海众启生物科技有限公司 一种脑梗塞生物标记物及其应用
CN115261457B (zh) * 2022-06-13 2023-10-27 广州市妇女儿童医疗中心 用于辅助诊断脑梗塞及其预后评价的标志物组合及含有其的试剂盒与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4070443B2 (ja) * 2001-10-11 2008-04-02 株式会社三菱化学ヤトロン 脳梗塞を検出する方法
GB0911060D0 (en) * 2009-06-26 2009-08-12 Ge Healthcare Uk Ltd Methods for predicting the toxicity of a chemical
US20120040858A1 (en) * 2010-08-13 2012-02-16 Morehouse School Of Medicine Biomarkers for stroke
EP2628013B1 (en) * 2010-10-14 2019-06-12 The Johns Hopkins University Biomarkers of brain injury
GB2497138A (en) * 2011-12-02 2013-06-05 Randox Lab Ltd Biomarkers for stroke and stroke subtype diagnosis.
KR20140145173A (ko) * 2012-03-26 2014-12-22 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 알츠하이머 질병 진단 및 알츠하이머 질병 진행 진단용 세포 마커

Similar Documents

Publication Publication Date Title
MX2017004559A (es) Receptores de celulas t.
JP2013172734A5 (enExample)
JP2017048194A5 (enExample)
EP3936141A3 (en) Anti-senescence compounds and uses thereof
EP3252172A3 (en) Fast hybridization for next generation sequencing target enrichment
EP4410805A3 (en) Raav-based compositions and methods for treating amyotrophic lateral sclerosis
MX2018001213A (es) Nuevos metodos para inducir una respuesta inmunitaria.
JP2015038108A5 (enExample)
IL251571A0 (en) Variable proteins comprising the cry1da1 amino acid sequence are activated by lepidopteran
WO2016115320A8 (en) Nucleic acid nanostructures with core motifs
WO2015107363A3 (en) Mycobacterial antigen composition
IL250646A0 (en) A process for conjugating a peptide or protein with a reagent containing a leaving group that includes a peg moiety
EP4059961A3 (en) Anti-tau constructs
JP2010265269A5 (enExample)
ECSP16076535A (es) Proteínas de fusión uti
JP2015129652A5 (enExample)
JP2015174855A5 (enExample)
EP3532044A4 (en) HDAC INHIBITOR COMPOSITIONS FOR CHROMOSOME X REACTIVATION
ES2609993B1 (es) Péptido para el tratamiento de la alergia
JP2016020396A5 (enExample)
TH168562A (th) กรดนิวคลีอิกและวิธีการสำหรับการตรวจหาเชื้อก่อโรคและจุลินทรีย์ที่เป็นประโยชน์
RU2016146358A (ru) Ингибитор холинорецептора
TH168983A (th) แคทไอออนิค นิวโรทอกซิน (Cationic Neurotoxins)
TH177981A (th) กระบวนการสำหรับการเตรียมกรด 3-ไฮดรอกซิพิโคลินิค
TH168459A (th) สารประกอบใหม่สำหรับการรักษาภาวะน้ำตาลในเลือดต่ำอย่างรุนเเรง